On Friday, Walgreen Co. was ordered by a jury to pay $25.8 million to the family of a cancer patient given a medication that caused a stroke and then several years later, death.

Beth Hippely was prescribed Warfarin, a blood thinner, in 2002 while being treated for breast cancer. According to court documents, the prescription she received at a Walgreen's pharmacy was 10 times what it should have been. The overdose caused a cerebral hemorrhage which led to permanent bodily injury, disability, pain, and then death. Hippely, a mother of three, died at the age of 46. Apparently, the error occurred when a 19-year-old pharmacy technician misfiled the prescription.

Hippely's family has been seeking justice for five years.

My port -- that thing that pops up from under the skin on my collarbone, that thing that by default stays in place because I can't decide whether or not to remove it -- is now officially in maintenance mode, now that my treatment for breast cancer is complete. My last Herceptin infusion was on June 28. And my first port flush was today. For as long as I keep my port -- and for as long as it has no real use -- I must have it flushed one time each month. So today, I strolled into the cancer infusion center where I've spent many hours and this time spent just a few minutes -- enough time for my usual chemo nurse to puncture the skin on top of my port, push through a rather large needle, and inject a dose of blood thinner into the lines of the port to keep clots away. The whole procedure was harmless, painless, no big deal at all. And I will return one month from today for a repeat performance.

One day these once-a-month visits may become a hassle. After all, I have to find a place for this appointment in my already-busy schedule and find childcare for my kids and find a place to park. I have to numb my port and endure a needle stick and sometimes fight traffic to get home. And the whole trip to and from the cancer center takes longer than the procedure itself. Clearly, this may be a waste of time for a port I don't even need right now. But at the moment, this visit is just what I need while I sort out the details of my post-treatment world. I need to go back to the infusion center. I need the comfort of the drive. I need to feel part of the chemo community. I need medical people swirling around me. I need a bit of hand holding. For now anyway.

I think obesity will always carry with it a risk for health problems. And according to a new study released on Monday, men with prostate cancer who are overweight have a higher risk of tumor recurrence after radiation treatment than thinner men do. Specifically, moderately and severely overweight men had a 70 percent higher risk of recurrence than men who were not overweight -- as indicated by rising levels of PSA, a blood protein that can signal prostate cancer. It is not clear how exactly obesity affects the success of radiation treatment -- perhaps it's the fat tissue that secretes certain hormones that helps the cancer progress at a later time. Regardless, the study suggests that men who are overweight do not fare as well as those who are at an average weight -- and this gives men a definite reason to trim down.

Obesity in this study was characterized by body mass index -- BMI -- a statistic that takes into account height and weight. A man five feet, 10 inches tall would be considered normal weight at or below 184 pounds. He would be overweight at 185 to 209 pounds, mildly obese at 210 to 244 pounds, and moderately to severely obese at above 244 pounds. Moderately to severely obese men had almost twice the risk of developing elevated PSA levels, according to an epidemiologist who led research in the study -- which will be published in the August 1 issue of the scientific journal Cancer.

This is my port. It looks to me like a bottle cap sewn under the skin on my chest. My son Joey -- he is five years old --  calls it my stone and his brother Danny -- he just turned three -- at one time thought everyone must have this same boo-boo. He would look for it, feel for it, hunt for it. But mine is the only port he could actually locate and now that he's getting older, he is not so concerned with it anymore.

My concern about the port is that everyone who needs chemotherapy should have one. It's the alternative to receiving IV sticks in the arms and hands and except for one quick stick that can sting -- I use a 5% lidocaine numbing cream prior to my infusion and with this miracle lotion, I don't feel a thing -- it is quick and painless. My port is a one-stop shop. Once accessed, blood can be drawn, drugs and fluids can be infused, shots can be injected, and at the end of treatment, an injection of blood thinner keeps the line clear and clean. The line attached to the port underneath my skin travels into large veins in a direct and efficient manner. While hospitalized for chemo-induced fever and low blood counts, I received antibiotics and a blood transfusion through this method. There was one stick when I was admitted and for my five-day stay, I never had to be poked again.

My port, called Infuse-a-Port®, was implanted during a minor outpatient surgery with use of a local anesthesia and it was ready for use immediately after the procedure.

My port has been used for 16 months now and will no longer be necessary at the end of July -- this is when the last drops of Herceptin will sail through my veins. Then I get to decide whether to keep my port or have it removed. It can stay for many years as long as it is flushed once each month. The superstitious part of me thinks I should keep it for future use -- if necessary -- and the rational part of me thinks I need to get rid of this bottle cap because I may never need it again. Regardless, I love my port. It has eased the discomfort of chemotherapy and for that, I am grateful.

Before I even get started, here is a sampling of the news headlines that are appearing in relation to a study indicating mothers who work outside the home are in better health than stay-at-home mothers. Working mothers less likely to become obese -- Working moms healthier than full-time homemakers -- Mothers who work enjoy better health -- Working Moms -- Healthier and thinner.

According to researchers who analyzed data from a study that tracked the health of women born in 1946 -- women who were employed outside the home were less likely than stay-at-home mothers and single mothers to report poor health or to be obese in middle age. Obesity is a known lifestyle factor contributing to a greater risk for a number of cancers. However, Dr Anne McMunn, of the University College in London, takes obesity into a debatable realm when she states that it has been known for some time that women who combine employment with motherhood and partnership have better health.